Natural Killer Cells

Natural Killer cells (NK cells) are essential to the early system surveillance function of the immune system. They are a type of white blood cell. NK cells attach to the antigen or unhealthy cell and inject granules into them. The granules destroy the antigen or unhealthy cell by inducing apoptosis.

The amount of granules in an NK cell determines its activity level. In immune deficient conditions the activity is low. A healthy activated NK cell can kill several diseased cells and microbes.

NK cells become activated in response to interferons or macrophage-derived cytokines. In the case of viral infections, for example, they serve to contain the spread while the adaptive immune response is generating antigen-specific cytotoxic T cells that can clear the infection.

Many studies show a link between NK cell deficiency and cancer, autoimmune diseases, infection susceptibility (e.g. Lyme Disease), and Chronic Fatigue Immune Dysfunction Syndrome (CFID). NK cells are known to kill invasive tumor cells. People deficient in NK cells prove to be susceptible to phases of Herpes virus and influenza virus infection.

Research on RBAC

RBAC has been the focus of scientific and clinical studies in Japan, the US, and Europe. Much of the research has been published in peer-reviewed journals. The information provided in this summary is from the research studies. The research includes in-vitro and in-vivo studies. The in-vivo work was performed in animals and humans.

A recent clinical study performed in Japan, showed that RBAC helped improve the quality of life and survival rate for people with stage III – IV cancer when taken in conjunction with another alternative cancer treatment that is the testing clinic’s standard therapy. In this study, the people in the control group used only the standard therapy and were found to have poor appetites with subsequent weight loss, extreme fatigue and high mortality rates. The group taking RBAC in conjunction with the standard treatment experienced improved appetites, and significantly higher survival rates.

In the research studies RBAC was evaluated and showed evidence of being of value for the following conditions:

Cancer, viral infections such as HIV, AIDS, Hepatitis B & C, bacterial infections, diabetes and inflammatory conditions such as rheumatoid arthritis.